PL2296643T3 - Kompozycja odżywcza do wspomagania ssaczego układu odpornościowego - Google Patents

Kompozycja odżywcza do wspomagania ssaczego układu odpornościowego

Info

Publication number
PL2296643T3
PL2296643T3 PL09770430.8T PL09770430T PL2296643T3 PL 2296643 T3 PL2296643 T3 PL 2296643T3 PL 09770430 T PL09770430 T PL 09770430T PL 2296643 T3 PL2296643 T3 PL 2296643T3
Authority
PL
Poland
Prior art keywords
improving
immune system
nutritional composition
mammalian immune
mammalian
Prior art date
Application number
PL09770430.8T
Other languages
English (en)
Inventor
Joyce Faber
Helvoort Adrianus Lambertus Bertholdus Van
Norren Klaske Van
Arjan Paul Vos
Robert Johan Joseph Hageman
Limpt Cornelus Johannes Petrus Van
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40380361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2296643(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of PL2296643T3 publication Critical patent/PL2296643T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Pediatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL09770430.8T 2008-06-23 2009-06-23 Kompozycja odżywcza do wspomagania ssaczego układu odpornościowego PL2296643T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2008/050414 WO2009157759A1 (en) 2008-06-23 2008-06-23 Nutritional composition for improving the mammalian immune system

Publications (1)

Publication Number Publication Date
PL2296643T3 true PL2296643T3 (pl) 2016-11-30

Family

ID=40380361

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09770430.8T PL2296643T3 (pl) 2008-06-23 2009-06-23 Kompozycja odżywcza do wspomagania ssaczego układu odpornościowego

Country Status (12)

Country Link
US (2) US20110150824A1 (pl)
EP (1) EP2296643B1 (pl)
CN (1) CN102131502B (pl)
BR (1) BRPI0914745B1 (pl)
DK (1) DK2296643T3 (pl)
ES (1) ES2582002T3 (pl)
HU (1) HUE029049T2 (pl)
MX (1) MX2011000022A (pl)
PL (1) PL2296643T3 (pl)
PT (1) PT2296643T (pl)
RU (1) RU2525429C2 (pl)
WO (2) WO2009157759A1 (pl)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200805905B (en) 2005-12-16 2009-10-28 Nutricia Nv Use of soluble dietary fibres against muscle wasting
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
EP2374452B1 (en) * 2008-12-05 2019-07-24 Ajinomoto Co., Inc. Nutrient composition
NL1037147C2 (nl) * 2009-07-23 2011-01-25 Opus Trade B V Samenstelling, werkwijze voor het produceren ervan en het gebruik ervan.
IT1399244B1 (it) * 2009-07-31 2013-04-11 Pharmarte S R L Formulazione di barretta specifica per la gravidanza.
US9457077B2 (en) 2009-11-18 2016-10-04 Katherine Rose Kovarik Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
US9585920B2 (en) 2011-02-04 2017-03-07 Katherine Rose Kovarik Method and system for treating cancer cachexia
BR112012027427A2 (pt) * 2010-04-26 2015-09-15 Nestec Sa composições nutritivas e métodos para a mudança da nutrição parenteral para a nutrição enteral
EP2444083A1 (en) 2010-10-21 2012-04-25 Nestec S.A. Cysteine and food intake
KR101743488B1 (ko) * 2010-11-30 2017-06-07 (주)아모레퍼시픽 비피더스균 추출물을 함유하는 지방유래 줄기세포의 줄기세포성 증진용 및 피부세포 증식용 조성물
US20120197067A1 (en) * 2011-01-31 2012-08-02 Primeval B.V. Nutritional Composition for Equine Reproductive Health
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10314865B2 (en) 2011-02-04 2019-06-11 Katherine Rose Kovarik Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US10940169B2 (en) 2015-11-30 2021-03-09 Joseph E. Kovarik Method for reducing the likelihood of developing cancer in an individual human being
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US9730967B2 (en) 2011-02-04 2017-08-15 Katherine Rose Kovarik Method and system for treating cancer cachexia
WO2012141575A1 (en) * 2011-04-14 2012-10-18 N.V.Nutricia Combination of epa, dpa and/or dha with a chemotherapeutic agent
WO2012177118A1 (en) 2011-06-22 2012-12-27 N.V. Nutricia Method for reducing the occurrence of infection in young children
RU2485964C1 (ru) * 2012-01-10 2013-06-27 Сергей Александрович Староверов Иммуностимулирующая композиция для животных
WO2013186233A1 (en) * 2012-06-12 2013-12-19 Norwegian University Of Science And Technology Composition
US9241923B2 (en) * 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US11026982B2 (en) 2015-11-30 2021-06-08 Joseph E. Kovarik Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11529379B2 (en) 2013-12-20 2022-12-20 Seed Health, Inc. Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
US11642382B2 (en) 2013-12-20 2023-05-09 Seed Health, Inc. Method for treating an individual suffering from bladder cancer
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11672835B2 (en) 2013-12-20 2023-06-13 Seed Health, Inc. Method for treating individuals having cancer and who are receiving cancer immunotherapy
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11213552B2 (en) 2015-11-30 2022-01-04 Joseph E. Kovarik Method for treating an individual suffering from a chronic infectious disease and cancer
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
CN106232577B (zh) 2014-04-25 2019-02-22 味之素株式会社 免疫刺激剂
CN103976359B (zh) * 2014-05-23 2016-01-13 汤臣倍健股份有限公司 食品营养强化组合物及其应用、保健食品及其制备方法
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
RU2608051C1 (ru) * 2015-07-03 2017-01-12 Махмуд Омарович Омаров Кормовая добавка для собак с антиоксидантным и иммуностимулирующим действием
WO2017073797A1 (en) 2015-10-28 2017-05-04 Ajinomoto Co., Inc. Immunostimulating agent
CN105231461A (zh) * 2015-10-30 2016-01-13 中营康园（北京）科技有限公司 一种提高机体免疫力的营养组合物及其应用
CN115252650A (zh) 2015-11-03 2022-11-01 布里格姆及妇女医院股份有限公司 用于治疗和/或预防食物变态反应的治疗性微生物群
SG11201804602SA (en) * 2015-12-03 2018-06-28 Meiji Co Ltd Nutritional composition
JP6949723B2 (ja) 2015-12-25 2021-10-13 大塚製薬株式会社 ゲル状食品組成物
GB201602626D0 (en) 2016-02-15 2016-03-30 Alchemy Foodtech Pte Ltd And Goh Zhi M V Glycemic reducing composition
HU231044B1 (hu) 2016-07-22 2020-01-28 Culex Patent Kft. Liponsav és szelenit szinergista hatásán alapuló készítmény és annak alkalmazása daganatos megbetegedések megelőzésében és kezelésében
CN106307504A (zh) * 2016-08-24 2017-01-11 华仁药业股份有限公司 一种用于慢性肾病患者的肠内营养组合物及其制备方法
JP7123945B2 (ja) 2016-10-03 2022-08-23 シャー，ホウン・サイモン がん放射線療法を増強するための組成物および方法
JP7788129B2 (ja) 2017-06-13 2025-12-18 シャー，ホウン・サイモン 癌化学療法を増強するための組成物および方法
US10905724B2 (en) 2017-06-13 2021-02-02 Houn Simon Hsia Compositions and methods for enhancing hyperthermia therapy
JP7336993B2 (ja) * 2017-06-13 2023-09-01 シャー，ホウン・サイモン 癌放射線療法を増強する組成物および方法
CN108851038A (zh) * 2018-05-08 2018-11-23 山东理工大学 糖尿病并发症肾病营养食品及其制备方法
WO2020002426A1 (en) 2018-06-27 2020-01-02 Arla Foods Amba Process for producing beta-lactoglobulin isolates and related methods and uses
CN112638421A (zh) * 2018-08-29 2021-04-09 帝斯曼知识产权资产管理有限公司 用于改善肠道健康的制剂
WO2020176564A1 (en) 2019-02-26 2020-09-03 The Regents Of The University Of Colorado, A Body Corporate Method and composition for treating gastrointestinal inflammatory disorders
WO2021053447A1 (en) * 2019-09-17 2021-03-25 Amitojas Wellness Private Limited Nutrition supplement for cancer patients
ES2974262T3 (es) 2019-11-20 2024-06-26 Arla Foods Amba Efectos insulinotrópicos y glucagonotrópicos de la beta-lactoglobulina
CN110882282A (zh) * 2019-12-13 2020-03-17 唐晓磊 一种调理肿瘤病患放化疗后肠道菌群失调的益生菌制剂及其应用
CN110960672B (zh) * 2019-12-18 2020-10-16 西南民族大学 一种提高牦牛免疫能力的aif-1蛋白注射液
CN111840523B (zh) * 2020-08-24 2021-08-31 中国农业科学院北京畜牧兽医研究所 一种含活性蛋白和活性脂肪酸的抗癌症的药物组合物
IT202200018804A1 (it) * 2022-09-14 2024-03-14 Abiogen Pharma Spa Composizione comprendente l-leucina e olio di pesce
CN116762952A (zh) * 2023-06-30 2023-09-19 西藏多欣健康科技有限公司 一种流质配方食品及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
CA2439293A1 (en) 2001-03-05 2002-09-12 Stephen P. Ernest Enteral formulation
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
JP4970694B2 (ja) * 2002-12-02 2012-07-11 株式会社明治 持続性筋肉疲労改善剤
GB0300602D0 (en) 2003-01-10 2003-02-12 Forinnova As Compositions
ATE361101T1 (de) * 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
EP1774973A1 (en) * 2005-10-12 2007-04-18 Nutricia N.V. Leucine rich composition
US20070116802A1 (en) 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
ZA200805905B (en) 2005-12-16 2009-10-28 Nutricia Nv Use of soluble dietary fibres against muscle wasting
WO2007114683A1 (en) * 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
CN101472612B (zh) * 2006-06-14 2011-06-08 纽崔西亚公司 包含甘氨酸和乳铁蛋白的抗炎组合物及其应用
CA2666871C (en) * 2006-10-19 2011-08-30 Nestec S.A. Long term feed - cancer patient
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system

Also Published As

Publication number Publication date
US10449248B2 (en) 2019-10-22
HUE029049T2 (en) 2017-01-30
RU2525429C2 (ru) 2014-08-10
CN102131502B (zh) 2014-12-03
US20110150824A1 (en) 2011-06-23
EP2296643B1 (en) 2016-04-20
BRPI0914745B1 (pt) 2021-01-26
DK2296643T3 (en) 2016-08-01
PT2296643T (pt) 2016-07-19
WO2009157759A1 (en) 2009-12-30
WO2009157767A1 (en) 2009-12-30
MX2011000022A (es) 2011-03-29
RU2011102393A (ru) 2012-07-27
BRPI0914745A2 (pt) 2015-10-20
EP2296643A1 (en) 2011-03-23
CN102131502A (zh) 2011-07-20
US20150004130A1 (en) 2015-01-01
ES2582002T3 (es) 2016-09-08

Similar Documents

Publication Publication Date Title
PT2296643T (pt) Composição nutricional para aprimorar o sistema imunitário de mamíferos
HRP20140203T1 (hr) Pripravci i metode za jaäśanje imunološkog sustava
GB0803967D0 (en) Queing System
IL208713A (en) Pharmaceutical preparation containing the r-dotap enantiomer to activate the immune system
PL2575504T3 (pl) Kompozycja odżywcza wykazująca właściwości immunologiczne
EP2373338A4 (en) ANNEXINA2 AS AN IMMUNOLOGICAL TARGET
IL265409B (en) Antibodies and processes for their preparation
PT2207787E (pt) Análogos de oligorribonucleótidos imunoestimulantes contendo frações de oligofosfato modificadas
ZA201100306B (en) Photovoltaic system
EP2293678A4 (en) ANGIOGENIC-ENRICHED MILK FRACTIONS
TWI561174B (en) Nutritional compositions containing punicalagins
GB0810459D0 (en) Furniture system
ZA201102082B (en) Immunological composition
ZA201106084B (en) Nutritional composition for infants
PL2547707T3 (pl) Kompozycje żywicy do wytwarzania paneli laminowanych z wysokim połyskiem
GB2450076B (en) Nutritional composition
GB0809298D0 (en) The back station
PL2125879T3 (pl) Mediator układu immunologicznego
GB0901669D0 (en) Chemiluminescent system
GB0919733D0 (en) Immune system modulating composition
PL2431052T3 (pl) Białko do kastracji immunologicznej dla ssaków
GB0814626D0 (en) The drink safe system
GB0810247D0 (en) The breakeasy system
GB0813425D0 (en) The parallel system
GB0809987D0 (en) The magnetic thrust system